Christine G. Kohn

1.3k total citations
46 papers, 954 citations indexed

About

Christine G. Kohn is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Christine G. Kohn has authored 46 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Internal Medicine, 22 papers in Cardiology and Cardiovascular Medicine and 12 papers in Epidemiology. Recurrent topics in Christine G. Kohn's work include Venous Thromboembolism Diagnosis and Management (24 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Acute Ischemic Stroke Management (10 papers). Christine G. Kohn is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (24 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Acute Ischemic Stroke Management (10 papers). Christine G. Kohn collaborates with scholars based in United States, United Kingdom and Israel. Christine G. Kohn's co-authors include Craig I Coleman, Elizabeth S. Mearns, C Michael White, Simon B. Zeichner, Alberto J. Montero, Thomas J. Bunz, Jeff Schein, Matthew W. Parker, Daniel A. Goldstein and W. Frank Peacock and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Christine G. Kohn

45 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine G. Kohn United States	17	335	297	157	156	153	46	954
S. Mueller Germany	14	466 1.4×	144 0.5×	132 0.8×	72 0.5×	74 0.5×	49	936
Alan Bell Canada	14	342 1.0×	112 0.4×	99 0.6×	270 1.7×	78 0.5×	53	997
J. Green United Kingdom	6	183 0.5×	265 0.9×	151 1.0×	205 1.3×	162 1.1×	7	1.2k
Su-Jung Chen Taiwan	21	800 2.4×	121 0.4×	267 1.7×	194 1.2×	122 0.8×	31	1.2k
Xin Du China	21	1.0k 3.0×	99 0.3×	214 1.4×	201 1.3×	95 0.6×	152	1.8k
Harun Kundi Türkiye	20	608 1.8×	122 0.4×	294 1.9×	425 2.7×	56 0.4×	70	1.4k
Dong‐Soo Kim South Korea	21	631 1.9×	85 0.3×	91 0.6×	509 3.3×	109 0.7×	91	1.3k
Tse‐Min Lu Taiwan	12	525 1.6×	65 0.2×	206 1.3×	265 1.7×	91 0.6×	56	1.1k
Thomas Kjellström Sweden	15	176 0.5×	166 0.6×	157 1.0×	225 1.4×	365 2.4×	43	1.1k
Luke Bamber United States	14	849 2.5×	655 2.2×	58 0.4×	187 1.2×	55 0.4×	27	1.1k

Countries citing papers authored by Christine G. Kohn

Since Specialization

Citations

This map shows the geographic impact of Christine G. Kohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine G. Kohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine G. Kohn more than expected).

Fields of papers citing papers by Christine G. Kohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine G. Kohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine G. Kohn. The network helps show where Christine G. Kohn may publish in the future.

Co-authorship network of co-authors of Christine G. Kohn

This figure shows the co-authorship network connecting the top 25 collaborators of Christine G. Kohn. A scholar is included among the top collaborators of Christine G. Kohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine G. Kohn. Christine G. Kohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kohn, Christine G., et al.. (2020). Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism. Blood Advances. 4(17). 4045–4051. 12 indexed citations

Dolinar, Richard, et al.. (2019). The non-medical switching of prescription medications. Postgraduate Medicine. 131(5). 335–341. 23 indexed citations

Coleman, Craig I, Thomas J. Bunz, Christine G. Kohn, & Jan Beyer‐Westendorf. (2018). Effectiveness and safety of rivaroxaban versus warfarin for treatment of cancer-associated venous thrombosis. Thrombosis Research. 164. S203–S203. 1 indexed citations

Nguyen, Elaine, et al.. (2018). Mechanical endovascular therapy for acute ischemic stroke: An indirect treatment comparison between Solitaire and Penumbra thrombectomy devices. PLoS ONE. 13(3). e0191657–e0191657. 10 indexed citations

Kohn, Christine G., Gary H. Lyman, Jan Beyer‐Westendorf, et al.. (2017). Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism. Blood. 130. 3717–3717. 3 indexed citations

Zeichner, Simon B., Daniel A. Goldstein, Christine G. Kohn, & Christopher R. Flowers. (2017). Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma. Journal of Gastrointestinal Oncology. 8(3). 513–523. 12 indexed citations

Kohn, Christine G., Simon B. Zeichner, Qiushi Chen, et al.. (2017). Cost-Effectiveness of Immune Checkpoint Inhibition inBRAFWild-Type Advanced Melanoma. Journal of Clinical Oncology. 35(11). 1194–1202. 90 indexed citations

Kohn, Christine G., Gregory J. Fermann, W. Frank Peacock, et al.. (2017). Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Current Medical Research and Opinion. 33(9). 1697–1703. 6 indexed citations

Nguyen, Elaine, Gary H. Lyman, Nicole M. Kuderer, et al.. (2017). Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta‐analysis. Journal of Thrombosis and Haemostasis. 16(2). 279–292. 11 indexed citations

10.

Diaby, Vakaramoko, Georges Adunlin, Askal Ayalew Ali, et al.. (2016). Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Research and Treatment. 160(1). 187–196. 42 indexed citations

11.

Ali, Askal Ayalew, Vakaramoko Diaby, Georges Adunlin, Christine G. Kohn, & Alberto J. Montero. (2016). PARAMETERIZATION OF A DISEASE PROGRESSION SIMULATION MODEL FOR SEQUENTIALLY TREATED METASTATIC HER2-POSITIVE BREAST CANCER PATIENTS. Value in Health. 19(3). A88–A88. 1 indexed citations

12.

Coleman, Craig I, Erin R. Weeda, W. Frank Peacock, et al.. (2016). IS RIVAROXABAN ASSOCIATED WITH SHORTER INPATIENT STAYS AND LOWER HOSPITAL COSTS VERSUS HEPARIN/WARFARIN IN LOW-RISK PULMONARY EMBOLISM PATIENTS?. Journal of the American College of Cardiology. 67(13). 2079–2079. 1 indexed citations

13.

Weeda, Erin R., Christine G. Kohn, Gregory J. Fermann, et al.. (2016). External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches. Thrombosis Journal. 14(1). 7–7. 12 indexed citations

14.

Coleman, Craig I, Nick Freemantle, & Christine G. Kohn. (2015). Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective. BMJ Open. 5(11). e008861–e008861. 10 indexed citations

15.

Coleman, Craig I, Christine G. Kohn, Concetta Crivera, Jeffrey Schein, & W. Frank Peacock. (2015). Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database. BMJ Open. 5(10). e009251–e009251. 13 indexed citations

16.

Coleman, Craig I, Christine G. Kohn, & Thomas J. Bunz. (2015). Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule. Current Medical Research and Opinion. 31(8). 1461–1468. 12 indexed citations

17.

Mearns, Elizabeth S., et al.. (2015). Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis. PLoS ONE. 10(4). e0125879–e0125879. 113 indexed citations

18.

Mearns, Elizabeth S., et al.. (2015). Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials. Journal of Thrombosis and Haemostasis. 13(6). 1043–1052. 17 indexed citations

19.

Mearns, Elizabeth S., C Michael White, Christine G. Kohn, et al.. (2014). Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thrombosis Journal. 12(1). 14–14. 83 indexed citations

20.

Coleman, Craig I, et al.. (2013). Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis. PLoS ONE. 8(1). e54756–e54756. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact